Background There is widespread, increasing use of magnesium sulphate in obstetric
practice for pre-eclampsia, eclampsia, and preterm fetal neuroprotection; benefit for …

Epidemiological knowledge of the incidence, prevalence, and temporal changes of neonatal
brachial plexuses palsy (NBPP) should assist the clinician, avert unnecessary interventions …

Effects and Safety of Magnesium Sulfate on Neuroprotection:... : Medicine Effects and Safety of
Magnesium Sulfate on Neuroprotection: A Meta-analysis Based on PRISMA Guidelines …

Presuming that the incidence of cerebral palsy (CP) in Korea is decreasing due to medical
advances, we analyzed the trends and risk factors of CP in changing circumstances. We …

Objective The authors investigated whether in utero exposure to selective serotonin
reuptake inhibitors (SSRIs) increases the risk of stillbirth or neonatal mortality. Method The …

Background Evidence supports magnesium sulphate (MgSO4) for women at risk of imminent
birth at< 32–34 weeks to reduce the likelihood of cerebral palsy in the child. MAGnesium …

Cerebral palsy is a group of neuromuscular diseases that is primarily common in the
pediatric population and is the most common cause of neurological and motor disability in …

The aim of our study was to assess the feasibility of implementing a protocol for the use of
magnesium sulfate to prevent cerebral palsy. This retrospective single-center study included …

Objective To compare two quality improvement (QI) interventions to improve antenatal
magnesium sulphate (MgSO4) uptake in preterm births for the prevention of cerebral palsy …

The rate of mortality and sequelae in preterm neonates has been decreasing over the years
worldwide. In great part, this is caused by improvements in neonatal care. However, the …